2013
DOI: 10.1016/j.amjcard.2013.02.027
|View full text |Cite
|
Sign up to set email alerts
|

Safety and Efficacy of Intense Antithrombotic Treatment and Percutaneous Coronary Intervention Deferral in Patients With Large Intracoronary Thrombus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
14
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 24 publications
1
14
0
Order By: Relevance
“…In the series as a whole, there were no acute events (ACS or sudden death). Previous studies investigated the feasibility of deferred PCI for STEMI treatment under optimal antithrombotic therapy, on the basis of angiographic findings only 39,40 . These series reported that this procedure could be performed safely in selected patients and also induced a decreased rate of culprit lesion stenting.…”
Section: Discussionmentioning
confidence: 99%
“…In the series as a whole, there were no acute events (ACS or sudden death). Previous studies investigated the feasibility of deferred PCI for STEMI treatment under optimal antithrombotic therapy, on the basis of angiographic findings only 39,40 . These series reported that this procedure could be performed safely in selected patients and also induced a decreased rate of culprit lesion stenting.…”
Section: Discussionmentioning
confidence: 99%
“…Embolic protection devices have also been used to decrease the risk of no-reflow in primary PCI, although the clinical or angiographic bene fits are unclear. 4,74 Reduced thrombotic burden in the culprit artery in patients with or without STEMI have also been reported with use of aspiration throm bectomy 5 or pharmacological prevention strategies, 75 which has been associated with decreased risk of no-reflow. All this evidence supports the hypothesis that embolization of microthrombi and plaque components from the culprit coronary segment are causative in no-reflow after PCI in patients with STEMI.…”
Section: The Role Of Ischaemiamentioning
confidence: 97%
“…In thrombolysis, regimens of intravenous thrombolytic agents were found to be as efficacious as intracoronary delivery (19). According to Mauro et al, intense antithrombotic treatment, including glycoprotein IIb/IIIa in-hibitors and PCI deferral (not performing PCI immediately), were safe and effective for acute coronary syndrome patients who had a large intracoronary thrombus (20). However, glycoprotein IIb/IIIa inhibitors are not available in Japan, and the intracoronary thrombus volume in our patient was more than 30 times greater than that reported by Mauro et al; therefore, we initially chose treatment with PCI.…”
Section: Discussionmentioning
confidence: 99%